Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IRB Problems Will Increase Congressional Pressure On Industry Trial Designs

Executive Summary

Congress may be looking to limit the flexibility that firms have in conducting clinical trials following a study that revealed operational shortcomings in the conduct and registration of Institutional Review Boards

You may also be interested in...



Single IRB Policy For Multi-Site Trials May Soon Get White House OK; NCI Hopeful

The White House appears close to finalizing a policy that would allow multi-site clinical trials to use only one institutional review board, which National Cancer Institute and other officials think could speed up and improve the process.

Single IRB Policy For Multi-Site Trials May Soon Get White House OK; NCI Hopeful

The White House appears close to finalizing a policy that would allow multi-site clinical trials to use only one institutional review board, which National Cancer Institute and other officials think could speed up and improve the process.

Who's Watching The Watchmen This Time? The Mystery Of The New IRB Sting

Institutional review boards appear to be facing vigilante regulation as FDA warns that someone is submitting fictitious studies for review.

Related Content

Topics

UsernamePublicRestriction

Register

PS050881

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel